114 related articles for article (PubMed ID: 6707230)
1. Augmentation of renal citrate excretion by oral potassium citrate administration: time course, dose frequency schedule, and dose-response relationship.
Pak CY; Skurla C; Brinkley L; Sakhaee K
J Clin Pharmacol; 1984 Jan; 24(1):19-26. PubMed ID: 6707230
[TBL] [Abstract][Full Text] [Related]
2. Long-term treatment of calcium nephrolithiasis with potassium citrate.
Pak CY; Fuller C; Sakhaee K; Preminger GM; Britton F
J Urol; 1985 Jul; 134(1):11-9. PubMed ID: 3892044
[TBL] [Abstract][Full Text] [Related]
3. Citraturic response to oral citric acid load.
Sakhaee K; Alpern R; Poindexter J; Pak CY
J Urol; 1992 Apr; 147(4):975-6. PubMed ID: 1552616
[TBL] [Abstract][Full Text] [Related]
4. The lack of influence of long-term potassium citrate and calcium citrate treatment in total body aluminum burden in patients with functioning kidneys.
Sakhaee K; Ruml L; Padalino P; Haynes S; Pak CY
J Am Coll Nutr; 1996 Feb; 15(1):102-6. PubMed ID: 8632109
[TBL] [Abstract][Full Text] [Related]
5. Contrasting effects of various potassium salts on renal citrate excretion.
Sakhaee K; Alpern R; Jacobson HR; Pak CY
J Clin Endocrinol Metab; 1991 Feb; 72(2):396-400. PubMed ID: 1899422
[TBL] [Abstract][Full Text] [Related]
6. Bioavailability of citrate from two different preparations of potassium citrate.
Harvey JA; Zobitz MM; Pak CY
J Clin Pharmacol; 1989 Apr; 29(4):338-41. PubMed ID: 2723122
[TBL] [Abstract][Full Text] [Related]
7. Bioavailability of potassium and magnesium, and citraturic response from potassium-magnesium citrate.
Koenig K; Padalino P; Alexandrides G; Pak CY
J Urol; 1991 Feb; 145(2):330-4. PubMed ID: 1988724
[TBL] [Abstract][Full Text] [Related]
8. Changes in urinary parameters after oral administration of potassium-sodium citrate and magnesium oxide to prevent urolithiasis.
Kato Y; Yamaguchi S; Yachiku S; Nakazono S; Hori J; Wada N; Hou K
Urology; 2004 Jan; 63(1):7-11; discussion 11-2. PubMed ID: 14751336
[TBL] [Abstract][Full Text] [Related]
9. [Clinical study of Urocit-K: a slow releasing potassium citrate].
Hwang TI; Yang CR; Lai LH
Zhonghua Yi Xue Za Zhi (Taipei); 1992 Mar; 49(3):194-8. PubMed ID: 1316212
[TBL] [Abstract][Full Text] [Related]
10. Idiopathic hypocitraturic calcium-oxalate nephrolithiasis successfully treated with potassium citrate.
Pak CY; Fuller C
Ann Intern Med; 1986 Jan; 104(1):33-7. PubMed ID: 3940503
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal citrate absorption in nephrolithiasis.
Fegan J; Khan R; Poindexter J; Pak CY
J Urol; 1992 May; 147(5):1212-4. PubMed ID: 1569651
[TBL] [Abstract][Full Text] [Related]
12. Potassium citrate decreases urine calcium excretion in patients with hypocitraturic calcium oxalate nephrolithiasis.
Song Y; Hernandez N; Shoag J; Goldfarb DS; Eisner BH
Urolithiasis; 2016 Apr; 44(2):145-8. PubMed ID: 26582172
[TBL] [Abstract][Full Text] [Related]
13. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
[TBL] [Abstract][Full Text] [Related]
14. Effect of orange juice consumption on urinary stone risk factors.
Wabner CL; Pak CY
J Urol; 1993 Jun; 149(6):1405-8. PubMed ID: 8501777
[TBL] [Abstract][Full Text] [Related]
15. Successful management of uric acid nephrolithiasis with potassium citrate.
Pak CY; Sakhaee K; Fuller C
Kidney Int; 1986 Sep; 30(3):422-8. PubMed ID: 3784284
[TBL] [Abstract][Full Text] [Related]
16. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
Pak CY; Sakhaee K; Fuller CJ
Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
[TBL] [Abstract][Full Text] [Related]
17. Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis.
Preminger GM; Sakhaee K; Skurla C; Pak CY
J Urol; 1985 Jul; 134(1):20-3. PubMed ID: 4009822
[TBL] [Abstract][Full Text] [Related]
18. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
19. The effects of a single evening dose of alkaline citrate on urine composition and calcium stone formation.
Berg C; Larsson L; Tiselius HG
J Urol; 1992 Sep; 148(3 Pt 2):979-85. PubMed ID: 1507355
[TBL] [Abstract][Full Text] [Related]
20. Alkali action on the urinary crystallization of calcium salts: contrasting responses to sodium citrate and potassium citrate.
Preminger GM; Sakhaee K; Pak CY
J Urol; 1988 Feb; 139(2):240-2. PubMed ID: 3339718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
